Jebaraj BMC, Muller A, Dheenadayalan RP, Endres S, et al. Evaluation of vecabrutinib as a model for non-covalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia. Blood 2021 Oct 18. pii: 477372. doi: 10.1182/blood.2021011516.
PMID: 34662393